266 related articles for article (PubMed ID: 2410522)
1. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
Parisien M; Charhon SA; Arlot M; Mainetti E; Chavassieux P; Chapuy MC; Meunier PJ
J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
[TBL] [Abstract][Full Text] [Related]
3. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
Sedman AB; Alfrey AC; Miller NL; Goodman WG
J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
[TBL] [Abstract][Full Text] [Related]
4. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
Andress DL; Maloney NA; Endres DB; Sherrard DJ
J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
[TBL] [Abstract][Full Text] [Related]
5. The evolution of osteomalacia in the rat with acute aluminum toxicity.
Rodriguez M; Felsenfeld AJ; Llach F
J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
[TBL] [Abstract][Full Text] [Related]
6. Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia.
Goodman WG
J Lab Clin Med; 1984 May; 103(5):749-57. PubMed ID: 6715954
[TBL] [Abstract][Full Text] [Related]
7. Experimental aluminum intoxication and parathormone: effects on the mineralization process.
Ballanti P; Mocetti P; Della Rocca C; Bonucci E; Costantini S; Giordano R; Ioppolo A; Mantovani A
Miner Electrolyte Metab; 1989; 15(4):233-40. PubMed ID: 2761490
[TBL] [Abstract][Full Text] [Related]
8. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
Andress DL; Maloney NA; Coburn JW; Endres DB; Sherrard DJ
J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
[TBL] [Abstract][Full Text] [Related]
9. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients.
Charhon SA; Berland YF; Olmer MJ; Delawari E; Traeger J; Meunier PJ
Kidney Int; 1985 Feb; 27(2):426-35. PubMed ID: 2581010
[TBL] [Abstract][Full Text] [Related]
10. Bone histology in adults with aseptic necrosis. Histomorphometric evaluation of iliac biopsies in seventy-seven patients.
Arlot ME; Bonjean M; Chavassieux PM; Meunier PJ
J Bone Joint Surg Am; 1983 Dec; 65(9):1319-27. PubMed ID: 6361038
[TBL] [Abstract][Full Text] [Related]
11. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
Lieuallen WG; Weisbrode SE
J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
[TBL] [Abstract][Full Text] [Related]
12. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
[TBL] [Abstract][Full Text] [Related]
13. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts.
de Vernejoul MC; Belenguer R; Halkidou H; Buisine A; Bielakoff J; Miravet L
Bone; 1985; 6(1):15-20. PubMed ID: 2581595
[TBL] [Abstract][Full Text] [Related]
14. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
[TBL] [Abstract][Full Text] [Related]
15. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
Visser WJ; Van de Vyver FL
Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
[TBL] [Abstract][Full Text] [Related]
16. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
Malluche HH; Goldstein DA; Massry SG
J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
Hodsman AB; Hood SA; Brown P; Cordy PE
J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
[TBL] [Abstract][Full Text] [Related]
19. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
Rapoport J; Chaimovitz C; Abulfil A; Mostovlavsky M; Gazit D; Bab I
Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
[TBL] [Abstract][Full Text] [Related]
20. Histological quantitation of aluminum in iliac bone from patients with renal failure.
Maloney NA; Ott SM; Alfrey AC; Miller NL; Coburn JW; Sherrard DJ
J Lab Clin Med; 1982 Feb; 99(2):206-16. PubMed ID: 6174656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
